This is a randomised, double-blind, placebo-controlled Phase 3 registration parallel arm study to evaluate the efficacy, safety and tolerability of 60 mg Promethean Health CBD daily vs. placebo in adults experiencing mild-to-moderate pain.
This Study is being conducted at our Western Sydney, Canberra, Central Coast and Brisbane Sites.
Apply Now
To assess the safety and tolerability of an investigational shingles vaccine (Zoster-1018) compared to Shingrix, an approved shingles vaccine, in adults aged 50-69 years.
This Study is being conducted at our Western Sydney, Central Coast and Brisbane Sites.
Apply Now
A Phase 4 Clinical Trial Comparing the Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate (FF/UMEC/VI) on Lung Function and Asthma Control in Adults with Uncontrolled Asthma Compared to the Usual Standard of Inhaled Corticosteroids/Long-Acting Beta-2 Agonists (ICS/LABA).
This Study is being conducted at our Western Sydney, Centeral Coast and Brisbane Sites.
Apply Now
A Phase 2 Clinical Trial Evaluating the Effectiveness of Alnylam’s potential New Add-On Treatment Zilebesiran versus Placebo on Blood Pressure Control in Adults with High Cardiovascular Risk that are currently taking two or more Anti-Hypertensive Treatments.
This Study is being conducted at our Western Sydney, Central Coast and Canberra Sites.
Apply Now
A Phase 1 study to investigate the safety and immunogenicity of an adjuvanted RSV/hMPV mRNA vaccine in adult participants aged 60 to 75 years.
This Study is being conducted at our Brisbane Site.
Apply Now
